Clinical Trials in Arizona

Showing 10921-10940 of 16,770 trials

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

NCT01926444

GIC-1001 is a novel, orally-administered, colonic analgesic drug developed as an alternative to i.v. sedation during full colonoscopy. It will be evaluated for efficacy and safety in a multi-center, randomized, double-blind, placebo controlled, dose-ranging, proof of concept Phase 2a trial. Up to 240 patients will receive one of 3 doses of GIC-1001 or its matching placebo. A pharmacokinetic evaluation will be carried out on a subset of patients (N: 24).

PainCancerColonic Diseases

gicare Pharma Inc.308 participantsStarted Jul 2013

Scottsdale, Arizona, United States • Anaheim, California, United States • Chula Vista, California, United States +12 more locations

COMPLETEDPhase 231 miles

A Phase2 of A-101 Topical Solution in Subjects With Common Warts

NCT03210337

The primary objective of this study is to evaluate the effectiveness of A-101 compared to vehicle when applied to 1 common target wart on the trunk or extremities.

Common Wart

Aclaris Therapeutics, Inc.157 participantsStarted Aug 2017

Scottsdale, Arizona, United States • Rogers, Arkansas, United States • San Diego, California, United States +14 more locations

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

A Phase2 of A-101 Topical Solution in Subjects With Common Warts

Find Trials by Condition in Arizona

Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump

Kybella With Triamcinolone

Melody® Transcatheter Pulmonary Valve Post-Approval Study

A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts

Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty

Fenzian Asthma Multicenter Outcomes Study

A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants